HealthyDirect · Growth
Aditya Birla Sun Life Pharma and Healthcare Fund
Aditya Birla Sun Life Mutual FundEquity Scheme - Sectoral/ Thematic7.2 years
The scheme seeks to provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.
- NAV
- 40.06
- 15 Sept 2026
- 1Y
- +17.5%
- Trailing CAGR
- AUM
- ₹1,102.73 Cr
- 31 Aug 2026
- Volatility
- Medium
- 15.1% annualized
NAV
Path not in current snapshots
n/a
Returns
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
- 1Y+17.5%
- 3Y+21.8%
- 5Y+14.4%
- 10Yn/a
- SI+21.4%
SIP XIRR
Equal monthly instalments to latest NAV
- 1Y+26.6%
- 3Y+17.4%
- 5Y+19.8%
- 10Yn/a
- Since inception
- +21.4%
- Calendar-day CAGR
- Excess 1Y
- +11.4%
- Category median, same plan and option
- 3Y win rate
- +62%
- Windows beating the median
- 3Y percentile
- 87
- Vs comparable share classes
- Worst rolling 3Y
- +11.8%
- 1029 daily-ending windows
- Median rolling 3Y
- +19.9%
- Calendar-day CAGR
- Positive rolling 5Y
- +100%
- 539 daily-ending windows
- SIP 3Y XIRR
- +17.4%
- Simulated monthly SIP
Drawdown
Peak to trough from a running NAV high. Move across the path to read a date.
Drawdown
Path not in current snapshots
n/a
- Average recovery
- 15 days
- 90 recovered episodes
- Longest recovery
- 431 days
- Trough to prior peak
- Current spell
- 11 days
- Days below latest peak
- Time below peak
- +86%
- NAV observations
16 Sept 2021 – 20 Jul 2023
Trough 17 Jun 2022 · recovered in 398 days
-20.5%
13 Feb 2020 – 9 Apr 2020
Trough 23 Mar 2020 · recovered in 17 days
-20.3%
9 Oct 2024 – 5 May 2026
Trough 28 Feb 2025 · recovered in 431 days
-15.9%
11 Jan 2021 – 9 Apr 2021
Trough 18 Mar 2021 · recovered in 22 days
-10.1%
Dimensions
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
87
Vs category
100
Consistency
59
Risk-adjusted
77
Drawdown
49
Mean
74
Portfolio
31 Aug 2026 · 40 holdings · top 10 are 54.1%.
- Top 5
- 35.3%
- Top 10
- 54.1%
- Largest holding
- 9.6%
- Effective holdings
- 23.3
Torrent Pharmaceuticals Ltd
Healthcare
9.6%
Sun Pharmaceutical Industries Ltd
Healthcare
9.2%
Apollo Hospitals Enterprise Ltd
Healthcare
6.9%
Cipla Ltd
Healthcare
5.2%
Aurobindo Pharma Ltd
Healthcare
4.5%
Decision
Quantitative read of the live evidence. An explanation can only restate what is already here.
As of 11 Sept 2026
Healthy
Engine status
Healthy
Doing its job
Why this status
- No material deterioration, cost shock, or persistent category underperformance in the current evidence set.
Supporting reads
- The fund beat the category median in 62% of rolling 3-year windows.
- Three-year return is above the category median.
- Risk-adjusted return sits above the documented risk-free proxy.
Worth investigating
Same-category peers with enough history to inspect beside this fund.
Baroda BNP Paribas Energy Opportunities Fund
Baroda BNP Paribas Mutual Fund
- 1Y
- +0.7%
- 3Y
- n/a
- Vol
- 13.8%
- Max DD
- -9.7%
- Sharpe
- 0.33
- 3Y win
- n/a
- Lower volatility
- Shallower drawdown
- Higher win rate vs category
Caveat: Lower trailing returns
ICICI PRUDENTIAL HOUSING OPPORTUNITIES FUND
ICICI Prudential Mutual Fund
- 1Y
- -3.4%
- 3Y
- +9.8%
- Vol
- 12.6%
- Max DD
- -16.7%
- Sharpe
- 0.67
- 3Y win
- +71%
- Lower volatility
- Shallower drawdown
- Higher win rate vs category
Caveat: Lower trailing returns
Kotak Business Cycle Fund
Kotak Mahindra Mutual Fund
- 1Y
- +2.5%
- 3Y
- +14.5%
- Vol
- 12.6%
- Max DD
- -18.4%
- Sharpe
- 0.82
- 3Y win
- +97%
- Lower volatility
- Shallower drawdown
- Higher win rate vs category
Caveat: Lower trailing returns
Motilal Oswal Active Momentum Fund
Motilal Oswal Mutual Fund
- 1Y
- +25.5%
- 3Y
- n/a
- Vol
- 17.1%
- Max DD
- -16.6%
- Sharpe
- 1.25
- 3Y win
- n/a
- Shallower drawdown
- Higher win rate vs category
- Higher trailing returns
Caveat: Higher volatility
Nippon India Innovation Fund
Nippon India Mutual Fund
- 1Y
- +0.2%
- 3Y
- +13.9%
- Vol
- 14.1%
- Max DD
- -21.5%
- Sharpe
- 0.68
- 3Y win
- +100%
- Lower volatility
- Higher win rate vs category
Caveat: Deeper drawdown · Lower trailing returns